52w high/low | ₹45.75 / ₹10.14 |
P/E ratio | 56.43 |
Dividend | 0 |
ROE | 21.68 |
ROCE | 23.87 |
Face value | 10 |
Book value | ₹27.31Cr |
Market capital | ₹390.31Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Incorporated as a public limited company in Oct. '94, Sanjivani Parenteral is jointly promoted by Anami H Khemka and a team of professionals in various fields of pharmaceutical industry. The company is setting up a plant at Taloja, Maharashtra, to manufacture high grade anti-biotics and life saving injectibles used in various infections, pre- and post-operative. The installed capacities for its products will be, 150 lac pa each for liquid vials and powder vials and 73 lac pa for its ampoules, taking the total capacity to 375 lac pa. The company came out with a public issue in Jan. '96 to part-finance the project. The promoters have received firm enquiries from reputed phamaceutical companies like Merind, Lupin Laboratories and USV for the first year' production of liquid vials and ampoules. During the year 1998-99, the Company has been approved by the WHO GMP Certificate.